Jan 09, 2025 18:00
SPRB - Spruce Biosciences, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
170.27 -6.35 (-3.73%) | --- | --- | --- | 1.75 (1.03%) | -12.32 (-7.18%) | 1.92 (1.19%) | 1.92 (1.19%) |
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.32
- Diluted EPS:
- -0.32
- Basic P/E:
- -512.25
- Diluted P/E:
- -512.25
- RSI(14) 1m:
- 100.0
- VWAP:
- 163.36
- RVol:
Events
Period | Kind | Movement | Occurred At |
---|
Related News
May 13, 2024 21:10
May 01, 2024 11:55
Mar 27, 2024 16:00
Mar 21, 2024 14:20
Mar 14, 2024 20:15
Mar 14, 2024 18:46
Mar 14, 2024 17:38
Mar 14, 2024 16:14
Mar 14, 2024 13:46